Exosome membrane-biomimetic nanomedicine targets the pre-metastatic niche

Rui Tang, Chengyu Mao, Caofang Hu, Wei Liu, Ju Bai, Yali Wang, Lijun Yang, Hongzhao Qi

Abstract read

In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rui TangInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, China.

Chengyu MaoInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, China.

Caofang HuInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, China.

Wei LiuDepartment of Emergency Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.

Ju BaiDepartment of Emergency Medicine, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.

Yali WangDepartment of Chemistry, College of Pharmacy, North China University of Science and Technology, Tangshan, 063210, China.

Lijun YangQingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao, 266101, China.

Hongzhao QiInstitute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao, 266021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer lung metastasis remains a major cause of mortality, largely driven by the formation of a pre-metastatic niche (PMN) through inflammatory signaling. Here, we report a biomimetic nanomedicine, EXO@m(PDTC), designed to target the pulmonary PMN and inhibit metastasis

Indexed as

Exosome membraneInflammationPDTCPre-metastatic nicheTumor metastasis

Identifiers

PMID41696155

DOI10.1016/j.mtbio.2026.102856

PMCPMC12906025

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.